Health committee  Thank you.

Health committee  Yes, I am. Isn't my picture there?

Health committee  Okay, then I do want to speak.

Health committee  Part of the problem with the economic analysis of values is what the appropriate measure is. What's typically used is the quality adjusted life year. And we're not even sure that that's the most appropriate measure. It becomes difficult. How are you going to put a value on being

Health committee  I'm not sure what the values are behind the judgments that lead to the Quebec formulary, but I think there's another possible explanation, and that is how they interpret the evidence. They are presented, really, with the same evidence. Those same binders go to every drug formular

Health committee  I did mention I'm a clinical investigator, so my research unit has received money to conduct clinical trials. I have also received consultancy fees from the Ontario drug benefit program, the CDR, as well as having consulted to various American government agencies for free.

Health committee  With respect to conflict of interest, it's certainly an issue that's foremost in my mind, because we are producing important guidelines for our members. You've touched on financial conflict of interest. What's perhaps even more compelling is intellectual conflict of interest, w

Health committee  I would like to address the issue of what comparators we use. Various panellists have mentioned comparing to Australia or Scotland or comparing to Medicare in the United States. I would say that I definitely know comparing to Medicare in the United States is not an appropriate me

Health committee  I don't think I can come up with a solution for the honourable member, but I'd like to address her concerns about how we can make the reviews more reflective of Canadian values. For the non-physicians in the group, I think it's important to understand what we mean by evidence-b

Health committee  Thank you, Mr. Chairman and the committee, for the opportunity to speak to you regarding my experiences both with CDR and the Ontario drug benefits program and in my role as a clinician-investigator, a clinician of patients with serious neurodegenerative diseases and an investiga

Health committee  Yes, I can hear you fine.